Description
Proleukin (aldesleukin) is a prescription biological therapy used for the treatment of adults with metastatic renal cell carcinoma (mRCC) and metastatic melanoma. As a form of immunotherapy, it works by stimulating the body's immune system to recognize and attack cancer cells. It is also used as a critical component in the manufacturing and administration of Tumor Infiltrating Lymphocyte (TIL) therapies like Amtagvi.
Best for
metastatic melanoma patients, renal cell carcinoma patients, TIL therapy regimens, immunotherapy specialists and oncology clinics